Skip to content

Medical-device intelligence

Lin-Zhi International Inc: FDA clearances and recalls

Research Lin-Zhi International Inc in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.

Names and coverage

This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.

Names observed in the source

Capitalization and punctuation variants are normalized. Customer-entered watchlist aliases remain private.

Product codes in this company’s records

Record activity in this scope

49 clearance records and 9 recall records in the covered releases, across 1 source company names and 18 product codes. Dated history runs from Apr 3, 2002 to Jan 16, 2026.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202610
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

58 matching records
Device / recordCompany in FDA recordSourceSource date
LZI Buprenorphine II Enzyme ImmunoassayK253082 · DJGLin-Zhi International, Inc.510(k)Jan 16, 2026FDA decision date
LZI Fentanyl III Enzyme ImmunoassayK251634 · DJGLin-Zhi International, Inc.510(k)Jun 18, 2025FDA decision date
LZI Oxycodone III Enzyme ImmunoassayK202007 · DJGLin-Zhi International, Inc.510(k)Sep 17, 2020FDA decision date
LZI Fentanyl II Enzyme ImmunoassayK201938 · DJGLin-Zhi International, Inc.510(k)Aug 7, 2020FDA decision date
LZI Tramadol Enzyme ImmunoassayK201223 · DJGLin-Zhi International, Inc.510(k)Jun 4, 2020FDA decision date
LZI Cotinine II Enzyme ImmunoassayK192299 · MKULin-Zhi International, Inc.510(k)Nov 21, 2019FDA decision date
LZI Methadone II Enzyme ImmunoassayK192433 · DJRLin-Zhi International, Inc.510(k)Oct 4, 2019FDA decision date
Ethyl Alcohol Enzymatic Assay, (a) REF 0220 (small test kit), (b) REF 0221 (large test kit) Product Usage: Detergent causes faster degradation …Z-1256-2019 · DICLin-Zhi International IncRecallMay 3, 2019FDA record creation date
LZI Fentanyl Enzyme ImmunoassayK181159 · DJGLin-Zhi International, Inc.510(k)Dec 3, 2018FDA decision date
LZI Methadone Metabolite Enzyme Immunoassay, LZI Methadone Metabolite (100 and 300) CalibratorsK170416 · DJRLin-Zhi International, Inc.510(k)Jun 26, 2017FDA decision date
LZI Oral Fluid Cannabinoids Enzyme Immunoassay, LZI Oral Fluid Cannabinoids Calibrators and LZI Oral Fluid Cannabinoids ControlsK141320 · LDJLin-Zhi International, Inc.510(k)May 28, 2015FDA decision date
LZI ORAL FLUID 6-ACETYLMORPHINE ENZYME IMMUNOASSAY, LZI ORAL FLUID 6-ACETYLMORPHINE CALIBRATORS (5 ML), LZI ORAL FLUID 6K141205 · DJGLin-Zhi International, Inc.510(k)Feb 13, 2015FDA decision date
LZI HYDROCODONE; ENZYME IMMUNOASSAY, CALIBRATORS; (5ML), (15ML); CONTROLS; (5ML), (15ML)K141055 · DJGLin-Zhi International, Inc.510(k)Jun 13, 2014FDA decision date
LZI ORAL FLUID METHAMPHETAMINE ENZYME IMMUNOASSAY, CALIBRATORS, CONTROLSK131652 · LAFLin-Zhi International, Inc.510(k)Mar 21, 2014FDA decision date
Single Analyte DAU Calibrator (5 mL) Norbuprenorphine: Cutoff Calibrator; IVD - for in vitro diagnostic use only; Lin-Zhi International Sunnyvale…Z-1270-2014 · DJGLin-Zhi International IncRecallMar 21, 2014FDA classification date
Cannabinoids DAU Calibrator Control Level 1 (37.5 ng/mL) This solution is prepared from non-sterile urine and should be handled as potentially i…Z-1178-2014 · DLJLin-Zhi International IncRecallMar 12, 2014FDA classification date
Cannabinoids DAU Calibrator Control Level 1 (62.5 ng/mL) This solution is prepared from non-sterile urine and should be handled as potentially i…Z-1179-2014 · JJWLin-Zhi International IncRecallMar 12, 2014FDA classification date
LZI MULTIPLE ANALYTE SET A;B;C DRUGS OF ABUSE CONTROLSK133710 · DKBLin-Zhi International, Inc.510(k)Feb 21, 2014FDA decision date
LZI ORAL FLUID AMPHETAMINE ENZYME IMMUNOASSAY, CALIBRATORS, CONTROLSK131653 · DKZLin-Zhi International, Inc.510(k)Feb 4, 2014FDA decision date
Single Analyte Urine DAU Control (5 m L Norbuprenorphine, Level II control For In Vitro Diagnostic Use Only. store at 2 - 8 degrees C. Contents: …Z-0386-2014 · LASLin-Zhi International IncRecallNov 25, 2013FDA classification date
LZI OXYCODONE HOMOGENEOUS ENZYME IMMUNOASSAY, LZI OXYCONDONE CALIBRATORS, LZI OXYCODONE CONTROLSK120763 · DJGLin-Zhi International, Inc.510(k)Jun 1, 2012FDA decision date
LZI OPIATE 2000 HOMOGENEOUS ENZYME IMMUNOASSAY, LZI OPIATE 2000 CALIBRATORS, LZI OPIATE 2000 CONTROLSK120761 · DJGLin-Zhi International, Inc.510(k)May 8, 2012FDA decision date
Multi-Analyte Urine DAU Calibrator (15 mL); Multi-Analyte,Intermediate Calibrator; for in-vitro diagnostic use only. Contains 300 ng/mL benzoylec…Z-0847-2012 · DKBLin-Zhi International IncRecallJan 25, 2012FDA classification date
Multi-Analyte Urine DAU Calibrator (15 mL HDPE bottle inside a cardboard box) For in vitro diagnostic use only. Lin-Zhi International, Inc.. 670…Z-0868-2012 · DKBLin-Zhi International IncRecallJan 25, 2012FDA classification date
Barbiturate Enzyme Immunoassay; R1 Antibody/Substrate Reagent (5000 tests and 500 tests); Contains a mixture of monoclonal and polyclonal anti-ba…Z-0846-2012 · DISLin-Zhi International IncRecallJan 24, 2012FDA classification date

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗